Pyoderma gangrenosum

What Is Pyoderma Gangrenosum?

Pyoderma gangrenosum, often abbreviated PG, is a rare, severe skin condition characterized by painful ulcers that develop and worsen with striking speed, sometimes progressing from a small, tender bump to a deep, extensive ulcer within just hours to days.¹

Despite its name, PG is not actually caused by an infection, gangrene, or any invading organism. Instead, it results from an inflammatory process within the immune system that damages skin tissue, meaning that treatments effective against infection, including antibiotics, do not address the underlying cause and can sometimes even allow the condition to worsen while a correct diagnosis is delayed.²

PG is strongly associated with underlying systemic disease, and more than half of affected patients have another significant inflammatory condition, most commonly inflammatory bowel disease, inflammatory arthritis, or certain blood cancers, occurring alongside their skin involvement.¹

Pyoderma gangrenosum is a rare ulcerative dermatosis characterized by rapidly progressive, painful ulcers, most commonly located on the lower extremities or trunk.
National Center for Biotechnology Information

Symptoms

PG typically begins as one or more small, red bumps or pustules that can be easily mistaken for a minor skin infection or insect bite in their earliest stage, before rapidly evolving into deep, painful ulcers with irregular, undermined borders.¹

The pain associated with PG is often disproportionate to what the wound’s initial appearance might suggest, and this severe, rapidly worsening pain, combined with the speed of ulcer progression, represents an important clue that distinguishes PG from many other causes of skin ulceration.²

A distinctive and clinically important feature of PG is a phenomenon called pathergy, in which new lesions can develop or existing ulcers can dramatically worsen at sites of minor trauma or surgical intervention, making biopsy and surgical treatment approaches genuinely risky without appropriate precautions.¹

Causes

The precise cause of PG remains incompletely understood, though it is now recognized as an inflammatory condition driven by dysregulated immune activity rather than an infectious process, involving abnormal activation of specific inflammatory cells and pathways within affected skin.¹

PG occurs frequently alongside inflammatory bowel disease, affecting roughly zero point four to two percent of patients with this underlying condition, and in some cases, the characteristic skin ulcers of PG can actually be the very first sign that leads to an eventual diagnosis of previously unrecognized inflammatory bowel disease.³

The pathergy phenomenon associated with PG means that surgical procedures, trauma, or even certain medical devices placed against the skin can trigger new lesions or worsen existing disease in susceptible individuals, an important consideration when planning any procedure in a patient with known or suspected PG.⁴

Risk Factors

A diagnosis of inflammatory bowel disease, whether Crohn’s disease or ulcerative colitis, represents one of the most significant risk factors for developing PG, and treating the underlying bowel disease often leads to meaningful improvement in associated skin lesions.⁵

Inflammatory arthritis, particularly rheumatoid arthritis, and certain blood cancers are also associated with elevated PG risk, reflecting the condition’s broader connection to systemic inflammatory and hematologic disease rather than representing a purely isolated skin condition.¹

A personal history of prior PG or a known predisposition to pathergy meaningfully raises the risk of new lesions developing following any future skin trauma or surgical procedure, an important consideration for ongoing patient care and any future medical interventions.⁴

Complications

Because PG progresses so rapidly and its distinctive pathergy phenomenon means surgical intervention can actively worsen the condition, misdiagnosis carries significant risk, including deep tissue infection, severe scarring, and, in the most serious cases, limb amputation.²

Misdiagnosis is remarkably common with PG, and studies have found the median time from symptom onset to correct diagnosis stretches to roughly fifteen days, with some cases taking considerably longer, during which patients may receive ineffective or actively harmful treatment based on an incorrect diagnosis.⁶

In severe cases, particularly when PG occurs alongside significant underlying illness, the condition can contribute to serious systemic complications, and rare fatalities have been reported in patients with substantial comorbid disease or associated infection of severely affected wounds.²

Treatment

Systemic corticosteroids represent the primary initial treatment for PG, working to rapidly suppress the underlying inflammatory process responsible for the disease’s characteristic rapid ulcer progression.²

Comprehensive wound care plays an essential complementary role alongside immunosuppressive medication, though it is critical that any wound care approach used avoids aggressive debridement or other interventions that could trigger pathergy and worsen the underlying ulcer.²

For patients with an identified underlying condition such as inflammatory bowel disease, treating that underlying disease often produces meaningful improvement in associated PG lesions, underscoring the importance of thorough evaluation for systemic disease in any newly diagnosed patient.⁵

Prevention

Because the precise cause of PG remains incompletely understood, there is no established or proven way to prevent the condition from developing in someone predisposed to it.¹

For patients with a known history of PG or an established predisposition to pathergy, avoiding unnecessary skin trauma and surgical procedures when possible, and ensuring any necessary future procedures are performed with appropriate precautions and awareness of this risk, can help reduce the likelihood of triggering new or worsening lesions.⁴

Prompt recognition and accurate diagnosis represent the most meaningful preventive measure available, since early, correct treatment substantially reduces the risk of the severe complications associated with prolonged misdiagnosis and inappropriate intervention.⁶

Why Visual Communication Matters for Pyoderma Gangrenosum

Explaining why a condition that looks like a severe infection is actually driven by the immune system, or why standard wound treatments like surgical debridement can dangerously worsen the disease, requires visuals that clearly communicate these counterintuitive but critically important clinical facts.²

Pharmaceutical companies, dermatology and wound care practices, and patient advocacy organizations rely on precise illustration and animation to explain PG and help prevent the dangerous misdiagnosis that so frequently affects this condition.

• Illustrating the rapid progression of PG lesions and how they differ from infection
• Animating the pathergy phenomenon and why surgical intervention poses risk
• Explaining the connection between PG and underlying systemic disease
• Visualizing appropriate wound care approaches that avoid worsening the condition
• Supporting clinical education aimed at reducing dangerous misdiagnosis
• Creating training materials for emergency and wound care clinicians

How Biotic Artlab Supports Pyoderma Gangrenosum Communication

We work with pharmaceutical companies, dermatology and wound care practices, and patient advocacy organizations to create accurate, engaging visuals that make PG and its distinctive clinical features easier to understand for patients and clinicians alike.

• Custom 3D animations of the inflammatory process underlying PG ulcer formation
• Detailed illustrations distinguishing PG from infectious causes of skin ulceration
• Clinical training content on pathergy and appropriate wound management
• Patient facing educational materials on symptom recognition and systemic associations
• Conference presentations for dermatology and wound care audiences
• Marketing and educational visuals for pharmaceutical and wound care product lines

Frequently Asked Questions

Is pyoderma gangrenosum contagious?

No. Despite its name and infection like appearance, PG is an inflammatory, immune driven condition rather than an infection, and it cannot be spread to other people through any form of contact.¹

Why is pyoderma gangrenosum so often misdiagnosed?

Its rapid ulcer progression closely resembles serious skin infections, and there is no single definitive test for PG, meaning it is diagnosed largely by ruling out other conditions, a process that frequently leads to delays and misdiagnosis.⁶

Why is surgery risky for pyoderma gangrenosum?

PG involves a phenomenon called pathergy, in which trauma, including surgical procedures such as debridement, can trigger new lesions or worsen existing ones, making standard surgical wound treatment potentially harmful rather than helpful.⁴

Is pyoderma gangrenosum related to bowel disease?

Often, yes. Inflammatory bowel disease is one of the most common conditions associated with PG, and in some patients, PG skin lesions actually lead to the discovery of previously undiagnosed bowel disease.³

How is pyoderma gangrenosum treated?

Treatment centers on systemic corticosteroids or other immunosuppressive medications to control the underlying inflammation, combined with careful, gentle wound care that specifically avoids aggressive debridement or other trauma that could worsen the condition.²

What should someone do if they suspect they have pyoderma gangrenosum?

Prompt evaluation by a dermatologist experienced with the condition is important, given how commonly it is misdiagnosed and the risk that inappropriate treatment, including unnecessary surgery, could worsen the underlying disease.⁶

Have a Project in Mind? Contact Us.

If you are developing patient education materials, clinical training content, or marketing visuals related to pyoderma gangrenosum or complex wound care, our team can help translate the science into visuals that are both accurate and easy to understand. Contact us at info@biotic-artlab.com or get in touch through our contact form to discuss your project.

References

1. National Center for Biotechnology Information. Pyoderma Gangrenosum as a Presenting Symptom of Inflammatory Bowel Disease.
2. National Center for Biotechnology Information. A Case of Pyoderma Gangrenosum Misdiagnosed as Necrotizing Infection, A Potential Diagnostic Catastrophe.
3. National Center for Biotechnology Information, StatPearls. Extraintestinal Manifestations of Inflammatory Bowel Disease.
4. National Center for Biotechnology Information. Pyoderma Gangrenosum Induced by Transcutaneous Electrical Nerve Stimulation, A Case Report With Literature Review.
5. National Center for Biotechnology Information. A Rare Case of Pyoderma Gangrenosum as a Complication of Ulcerative Colitis, A Case Report and Literature Review.
6. National Center for Biotechnology Information. Early Diagnosis and Treatment of Pyoderma Gangrenosum, Reviewing Mobile Phone Photos Saved a Patient From Unnecessary Surgeries.

Disclaimer: This page provides general educational information and is not a substitute for diagnosis, treatment, emergency care, or individualized advice from a qualified healthcare professional.